Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 16 | ECE2008 | Next issue

10th European Congress of Endocrinology

Poster Presentations

Diabetes and cardiovascular diseases

Previous section
Comparative endocrinology
Table of contents
Next section
Endocrine disruptors

ea0016p172 | Diabetes and cardiovascular diseases

Changes in the sympathetic and sensory innervation of the tail artery, adrenal gland and male reproductive organs of glucose-intolerant Goto-Kakazaki (GK) rats

ea0016p173 | Diabetes and cardiovascular diseases

Anxieties of type one diabetic patients

ea0016p174 | Diabetes and cardiovascular diseases

Opportunistic screening for type 2 diabetes mellitus in the out-patient clinic: experience from Basrah, Southern Iraq

ea0016p175 | Diabetes and cardiovascular diseases

Long term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes mellitus

ea0016p176 | Diabetes and cardiovascular diseases

Adiponectin stimulates monocytic release of CCL2, -3, -4 and -5 concomitantly reduces the surface abundance of CCR1, -2 and -5

ea0016p177 | Diabetes and cardiovascular diseases

Effects of the omega-3 polyunsaturated fatty acids in the treatment of cardiovascular autonomic neuropathy in Type 2 diabetes mellitus patients

ea0016p178 | Diabetes and cardiovascular diseases

Omega-3 polyunsaturated fatty acids and simvastatin in the treatment of type 2 diabetic patients with cardiomyopathy

ea0016p179 | Diabetes and cardiovascular diseases

Degree of control of cardiovascular risk factors (CRFs) in patients with type 2 diabetes mellitus (T2DM) stratified by diabetes therapy

ea0016p180 | Diabetes and cardiovascular diseases

Determination of asymptomatic interacranial stenotic arteries in diabetic and hypertensive old patients by transcranial doppler sonography

ea0016p181 | Diabetes and cardiovascular diseases

The impact of family history of type 2 diabetes mellitus on insulin sensitivity in lean subjects with polycystic ovary syndrome

ea0016p182 | Diabetes and cardiovascular diseases

Rapid acting insulin analogues are superior to normal human insulin in intensified insulin treatment of type 2 diabetes mellitus

ea0016p183 | Diabetes and cardiovascular diseases

Melatonin--insulin relationships in rats and humans

ea0016p184 | Diabetes and cardiovascular diseases

Effects of micronutrients supplementation on lipid peroxidation in Type 2 diabetes

ea0016p185 | Diabetes and cardiovascular diseases

Metabolic improvement in diabetic patients under education before implantation of the insulin sibcutaneous continuous infusion (ISCI)

ea0016p186 | Diabetes and cardiovascular diseases

Comparison of patient's life quality between inhalated insulin therapy (Exubera) and conventional treatment

ea0016p187 | Diabetes and cardiovascular diseases

Satisfaction degree and metabolic control in patients with glucose continuous monitoring system

ea0016p188 | Diabetes and cardiovascular diseases

Metabolic control and quality of life in patients with DM1 and insulin pump therapy

ea0016p189 | Diabetes and cardiovascular diseases

Utility of ambulatory blood pressure monitoring in diabetological consulting

ea0016p190 | Diabetes and cardiovascular diseases

The knowledge of society about risk factors for cardiovascular diseases like obesity and prevention of it

ea0016p191 | Diabetes and cardiovascular diseases

Mediterranean-style diet attenuates inflammation and atherosclerosis markers in type 2 diabetic patients

ea0016p192 | Diabetes and cardiovascular diseases

Endothelin-1 is correlated with TGF-β1 but not with glycemic control in normotensive subjects with type 2 diabetes

ea0016p193 | Diabetes and cardiovascular diseases

Use of three dose premixed aspart: clinical correlates

ea0016p194 | Diabetes and cardiovascular diseases

Relationship between admission blood glucose (ABG) and homocysteine (HC) levels in patients with acute coronary syndromes (ACS)

ea0016p195 | Diabetes and cardiovascular diseases

K121Q PC-1 gene polymorphism is not associated with postpartum type 2 diabetes in gestacional diabetes mellitus patients

ea0016p196 | Diabetes and cardiovascular diseases

Improvement of exercise capacity, muscle strength and insulin resistance in elderly patients with heart failure after treatment with long acting testosterone: a randomized clinical trial

ea0016p197 | Diabetes and cardiovascular diseases

Circulating Reg1-α plasma levels: potential marker of beta cell regeneration?

ea0016p198 | Diabetes and cardiovascular diseases

Influence of ethnicity on prevalence of gestational diabetes

ea0016p199 | Diabetes and cardiovascular diseases

24 h glycemia variability correlates with arterial structure alteration in type 1 diabetes

ea0016p200 | Diabetes and cardiovascular diseases

Relationship between nerve conduction velocity with uncoupling protein 2 promoter polymorphism -866G/A and A allele frequency in type 2 diabetic patients with diabetic peripheral neuropathy

ea0016p201 | Diabetes and cardiovascular diseases

No genetic impact of the SOCS3-gene on T2DM

ea0016p202 | Diabetes and cardiovascular diseases

Atherosclerosis in premenopausal diabetic women with or without polycystic ovary syndrome

ea0016p203 | Diabetes and cardiovascular diseases

Effects of testosterone and sildenafil on cytokines and angiogenic factors: a randomized controlled trial

ea0016p204 | Diabetes and cardiovascular diseases

Smoking shortens insulin-free interval in type 2 diabetics

ea0016p205 | Diabetes and cardiovascular diseases

Glycemic variability analyze with different glucometers

ea0016p206 | Diabetes and cardiovascular diseases

Evaluation of continuous subcutaneous insulin infusion in type 1 diabetes

ea0016p207 | Diabetes and cardiovascular diseases

Elevated plasma fatty acid levels are associated with myocardial triglyceride accumulation and diastolic dysfunction in type 2 diabetes mellitus which can be reversed by acipimox

ea0016p208 | Diabetes and cardiovascular diseases

May testosterone therapy be the key to metabolic syndrome (MS) treatment in men?

ea0016p209 | Diabetes and cardiovascular diseases

Relationship of insulin sensitivity with carotid intima media thickness in patients with type 2 diabetes mellitus

ea0016p210 | Diabetes and cardiovascular diseases

Diabetic survival with HD: 10-years follow-up

ea0016p211 | Diabetes and cardiovascular diseases

Markers of oxidative stress and antioxidant status in patients with gestational diabetes

ea0016p212 | Diabetes and cardiovascular diseases

Adipokine profile in gestationa diabetes mellitus

ea0016p213 | Diabetes and cardiovascular diseases

Patients with type 2 diabetes mellitus have intima media thickness of carotid artery wall equal to that of a decade older non-diabetic patients

ea0016p214 | Diabetes and cardiovascular diseases

Kidney transplantation and diabetes mellitus: continuous monitoring of glucose

ea0016p215 | Diabetes and cardiovascular diseases

Metabolic changes induced by glucose infusion in persons with Glu23Lys polymorphism

ea0016p216 | Diabetes and cardiovascular diseases

Effects of testosterone administration in male patients with heart failure with and without hypogonadism

ea0016p217 | Diabetes and cardiovascular diseases

GC-tofMS metabolite profiling in the pancreatic beta cell line INS-1 under chronic glucose stress conditions

ea0016p218 | Diabetes and cardiovascular diseases

Diabetes management and metabolic control are below expectations in specialist diabetes practice in Portugal

ea0016p219 | Diabetes and cardiovascular diseases

Glucose metabolism alterations in non-diabetic patients undergoing cardiac rehabilitation programs

ea0016p220 | Diabetes and cardiovascular diseases

GDM in women younger and older than 28 years: are there any differences in phenotype and biochemical markers?

ea0016p221 | Diabetes and cardiovascular diseases

SelS/Tanis controls insulin sensitivity and is regulated by acute phase and diet

ea0016p222 | Diabetes and cardiovascular diseases

Atherosclerotic factors, low antioxidant defense and cardiovascular diseases in retinal occlusions and anterior ischemic optic neuropathy

ea0016p223 | Diabetes and cardiovascular diseases

Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in polycystic ovary syndrome

ea0016p224 | Diabetes and cardiovascular diseases

Atorvastatin ameliorates penile erection and sildenafil responsiveness in two distinct animal models of chemical diabetes and inhibits high glucose-induced alterations in human penile smooth muscle cells

ea0016p225 | Diabetes and cardiovascular diseases

Circulating endotoxin as a potential biomarker and mediator of inflammation: influenced by diabetic therapies

ea0016p226 | Diabetes and cardiovascular diseases

Serum adiponectin concentration is not dependent on inflammatory process of periodontium in patients with primary hypertension: preliminary results

ea0016p227 | Diabetes and cardiovascular diseases

The association between adipocytokine profiles and insulin resistance in obese subjects

ea0016p228 | Diabetes and cardiovascular diseases

Vitamin D deficiency is associated with heart failure and sudden cardiac death: cross-sectional and mortality data of 3299 patients referred to coronary angiography

ea0016p229 | Diabetes and cardiovascular diseases

Retrovirally transduced, antigen-specific T cells for therapy of type 1 diabetes

ea0016p230 | Diabetes and cardiovascular diseases

Induction of autoantigen-specific tolerance by retroviral transduction of hematopoetic stem cells with GAD65

ea0016p231 | Diabetes and cardiovascular diseases

Cardiac autonomic and peripheral neuropathy in newly diagnosed type 2 diabetic patients

ea0016p232 | Diabetes and cardiovascular diseases

Severity of depression in patients with type 1 and type 2 diabetes and its relation to the level of glycemia control and anti-depressive therapy

ea0016p233 | Diabetes and cardiovascular diseases

Quality of diabetes shared care in patients with diabetes type 2 in the diabetes clinic of Fredericia hospital

ea0016p234 | Diabetes and cardiovascular diseases

Cardiac autonomic neuropathy in relation to some components of metabolic syndrome in newly diagnosed type 2 diabetic patients

ea0016p235 | Diabetes and cardiovascular diseases

Cumulative incidence, timing and risk factors for thyroid dysfunction in 144 Romanian patients treated with amiodarone

ea0016p236 | Diabetes and cardiovascular diseases

Changes in glucose profiles in fasting patients with type 2 diabetes mellitus during Ramadan: analysis of CGMS data in patients in the UAE

ea0016p237 | Diabetes and cardiovascular diseases

Diabetic ketoacidosis in two periods: XX--XXI centuries

ea0016p238 | Diabetes and cardiovascular diseases

Endothelin-1 and diabetes: influence of cronic metabolic control

ea0016p239 | Diabetes and cardiovascular diseases

Subclinical alterations of blood pressure associated to clasical cardiovascular risk factors in patients with type 1 diabetes

ea0016p240 | Diabetes and cardiovascular diseases

Cognitive dysfunction in diabetics: can we predict it, can we protect them?

ea0016p241 | Diabetes and cardiovascular diseases

Iliofemoral arterial occlusion in type 2 diabetics shortens life duration to the greatest extent: 10 years follow up study

ea0016p242 | Diabetes and cardiovascular diseases

Influence of obesity and insulin resistance on scavenger receptor CD36 expression on monocytes in young women

ea0016p243 | Diabetes and cardiovascular diseases

Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy

ea0016p244 | Diabetes and cardiovascular diseases

Psychological symptoms and quality of life among diabetic patients: a comparative study

ea0016p245 | Diabetes and cardiovascular diseases

Correlation between inflammation markers and plasma fasting glucose in overweight and obese women

ea0016p246 | Diabetes and cardiovascular diseases

Phenotypically heterogenous neonatal diabetes within one family caused by a new mutation in the sulphonylurea receptor SUR1 (ABCC8)

ea0016p247 | Diabetes and cardiovascular diseases

Continuous subcutaneous insulin infusion with U-500 insulin is better than pramlintide in highly insulin resistant patient with type 2 diabetes

ea0016p248 | Diabetes and cardiovascular diseases

Systematic exercise can further improve glycaemic control and physical fitness in physically active women with type 2 diabetes

ea0016p249 | Diabetes and cardiovascular diseases

Early major complications at diabetics in coronary care unit

ea0016p250 | Diabetes and cardiovascular diseases

Nebivolol in diabetic patients with chronic heart failure

ea0016p251 | Diabetes and cardiovascular diseases

Frequency of hypertension studied by ambulatory blood pressure monitoring in type two diabetes

ea0016p252 | Diabetes and cardiovascular diseases

Concentrations of steroid hormones different from estradiol may constitute risk factors of coronary artery disease in women

ea0016p253 | Diabetes and cardiovascular diseases

The stress-related protein p8 protects beta cells from streptozotocin (STZ)-induced cell death in vitro

ea0016p254 | Diabetes and cardiovascular diseases

Increased serum AGEs is a distinct finding in lean women with PCOS

ea0016p255 | Diabetes and cardiovascular diseases

Importance of vasopressin and aldosterone for clinical outcome of patients after cardiac arrest

ea0016p256 | Diabetes and cardiovascular diseases

Concentration of interleukins as prognostic factor in patients after cardiac arrest

ea0016p257 | Diabetes and cardiovascular diseases

Cytokines secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grae systemic inflammation

ea0016p258 | Diabetes and cardiovascular diseases

Rapid glucose spray™ for the management of hypoglycaemia in children with type 1 diabetes

ea0016p259 | Diabetes and cardiovascular diseases

Obestatin inhibits high glucose-induced reactive oxygen species production and apoptosis in bovine aortic endothelial cells

ea0016p260 | Diabetes and cardiovascular diseases

The high prevalence of testosterone deficiency syndrome and erectile dysfunctions in the aging men with diabetes mellitus type 2

ea0016p261 | Diabetes and cardiovascular diseases

The influence of testosteone replacement therapy on erectile dysfunctions in aging men with testosterone deficiency and diabetes mellitus type 2

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more